Dr. Brian Hafler has been named a recipient of the 2026 Colton Fund Award through Yale Ventures, recognizing his innovative translational research in retinal degeneration, neuroinflammation, and regenerative biology. The award supports promising early-stage projects with the potential to advance scientific discovery and accelerate therapeutic innovation. Dr. Hafler’s work combines cutting-edge single-cell and translational research approaches to better understand retinal and neurodegenerative diseases, identify new therapeutic targets, and bridge the gap between laboratory discoveries and clinical applications. This recognition highlights both the impact of his research program and Yale Ophthalmology & Visual Science’s continued leadership in advancing vision science and improving patient care.